BIA-ALCL: Historical FDA Medical Device Report Data
1 Oct 2026 · 0 min
0:12
In this brief excerpt, Dr. Robert Whitfield references the FDA's April 2022 tabulation of Breast Implant‑Associated Anaplastic Large Cell Lymphoma (BIA‑ALCL). The FDA recorded 1,130 unique ALCL cases in its medical device reports, and approximately 71% of those reports identified a textured implant surface as a factor. The statement underscores the historical prevalence of textured implants among reported BIA‑ALCL cases.
